![Dave Grayzel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dave Grayzel
Plus aucun poste en cours
Fortune : - $ au 31/08/2026
Profil
Dave S.
Grayzel was the founder of Ataxion, Inc. founded in 2013, serving as Chief Executive Officer & Director.
Dr. Grayzel was the founder of Annovation BioPharma, Inc. founded in 2011, serving as Chief Executive Officer from 2011 to 2015.
Dr. Grayzel was the founder of Arteaus Therapeutics LLC founded in 2011, serving as Chief Executive Officer from 2011 to 2014.
Dr. Grayzel was the founder of Surface Oncology, Inc. founded in 2014, serving as Chairman from 2015 to 2017.
Dr. Grayzel is the founder of Acera School founded in 2009, serving as Director since 2009.
Dr. Grayzel is the founder of Q32 Bio, Inc. founded in 2024, serving as Independent Director since 2024.
Dr. Grayzel was also the founder of Cadent Therapeutics, Inc...
Current positions included Director at Q32 Bio Operations, Inc. since 2020; Independent Director at Affinia Therapeutics, Inc. since 2020; Director at TRIANA Biomedicines, Inc.; Director at Comanche Biopharma Corp.; Director at Radera Biotherapeutics, Inc.; Director at Vima Therapeutics, Inc.; Partner at Atlas Venture Advisors, Inc. since 2014; Advisor at Memorial Sloan Kettering Cancer Center; Partner at Atlas Venture Life Science Advisors LLC since 2014; Member at Tri-Institutional Therapeutics Discovery Institute, Inc.; Member at One Brave Idea, Inc. Former positions include Director of Corporate Development at Dyax Corp.
from 2000 to 2002; Curriculum Director at Stanford Health Care-Stanford Hospital; Director at Xilio Therapeutics, Inc. from 2018 to 2021; Director at Delinia, Inc. from 2015 to 2017; Independent Director at Jade Biosciences, Inc. from 2020 to 2025; VP-Clinical Development & Medical Affairs at Infinity Pharmaceuticals, Inc. from 2002 to 2010; Principal at Quartet Medicine, Inc. Education includes undergraduate degree from Stanford University and doctorate from Harvard Medical School conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 12/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Dave Grayzel
| Sociétés | Poste | Début |
|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2010 |
Acera School | Fondateur | 01/01/2009 |
Tri-Institutional Therapeutics Discovery Institute, Inc.
 Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates scientific and medical institutions that works to more effectively develop therapeutics | Corporate Officer/Principal | - |
One Brave Idea, Inc.
 One Brave Idea, Inc. Miscellaneous Commercial ServicesCommercial Services Operates science innovation center | Corporate Officer/Principal | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Directeur/Membre du Conseil | 22/12/2020 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Directeur/Membre du Conseil | 01/03/2020 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Consultant / Advisor | - |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/01/2014 |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Dave Grayzel
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Dave Grayzel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Develops novel therapies for migraine prevention | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Stanford Health Care
 Stanford Health Care Hospital/Nursing ManagementHealth Services Operates as healthcare center | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
Ataxion, Inc.
 Ataxion, Inc. BiotechnologyHealth Technology Develops novel therapies for rare, debilitating, and underserved neurologic diseases | Health Technology |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Acera School | |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Finance |
Tri-Institutional Therapeutics Discovery Institute, Inc.
Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates scientific and medical institutions that works to more effectively develop therapeutics | Commercial Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Delinia, Inc.
 Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
One Brave Idea, Inc.
One Brave Idea, Inc. Miscellaneous Commercial ServicesCommercial Services Operates science innovation center | Commercial Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Comanche Biopharma Corp.
 Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical biopharmaceutical company which develops a novel siRNA therapy for the treatment of preeclampsia | Commercial Services |
